Details for Patent: 10,961,195
✉ Email this page to a colleague
Which drugs does patent 10,961,195 protect, and when does it expire?
Patent 10,961,195 protects AKYNZEO and is included in one NDA.
This patent has eight patent family members in eight countries.
Summary for Patent: 10,961,195
Title: | Crystalline forms of an NK-1 antagonist |
Abstract: | The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1- -yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders. |
Inventor(s): | Bacilieri; Christian (Breganzona, CH), Frasca; Gionata (Minusio, CH) |
Assignee: | Helsinn Healthcare SA (Pazzallo, CH) |
Application Number: | 16/863,038 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 10,961,195
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,961,195
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015323515 | ⤷ Sign Up | |||
Canada | 2960599 | ⤷ Sign Up | |||
China | 107001275 | ⤷ Sign Up | |||
European Patent Office | 3197871 | ⤷ Sign Up | |||
Japan | 2017529380 | ⤷ Sign Up | |||
South Korea | 20170063768 | ⤷ Sign Up | |||
Taiwan | 201613888 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |